Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
株式のランク #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
株価
$0.00023723
最終同期: 2024-08-26
時価総額
$1.41K
変化(1日)
111.67%
変化(1年)
0.00%
FR
取引 Pharnext S.A. (ALPHA)

カテゴリー

Pharnext S.A.(ALPHA)の発行済株式数
December 2023 時点の発行済株式数 736.02K
Pharnext S.A. の最新の財務報告および株価によると、現在の発行済株式数は 736.02K です。December 2022 の終わりには、同社は 736.02K 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Pharnext S.A.(ALPHA)の発行済株式数の履歴(2013 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 736.02K 0.00%
2023 736.02K 0.00%
2022 736.02K 0.00%
2021 736.02K 0.00%
2020 736.02K 0.00%
2019 736.02K 0.00%
2018 736.02K 0.00%
2017 736.02K 0.00%
2016 736.02K 0.00%
2015 736.02K 0.00%
2014 736.02K 0.00%
2013 736.02K 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数
253.90M 34,396.16%
US
62.19M 8,348.83%
NL
- -
CH
0.00 -100.00%
BE
- -
KR